At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4 enrolled
Drug / intervention
Midazolam Hydrochloride 2Mg/mL Syrup +1 moredrug
Likely dose
Midazolam Hydrochloride 2Mg/mL Syrupfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Oral Anxiolysis for the Older Pediatric Patient-Which Medication is Preferred?
In Brief
A clinical study evaluating Midazolam Hydrochloride 2Mg/mL Syrup and Triazolam 0.125 MG for Dental Anxiety. Completed, enrolled 4 participants across 1 site.
Detailed Summary
This study will evaluate the perceptions of the effects of two anxiolytic medications commonly used during dental treatment in patients weighing 40 kilograms or more.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Anxiety
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 2017
Enrollment StartJan 2018
Primary CompletionApr 2018
TodayJul 2026
First PostedDec 2, 2017
Enrollment StartJan 26, 2018
Primary CompletionApr 11, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.6 years ago
Interventions
Midazolam Hydrochloride 2Mg/mL Syrupdrug
Midazolam HCl Syrup 0.5mg/kg (Max: 15mg) taken 10-15 minutes prior to dental treatment.
Triazolam 0.125 MGdrug
Triazolam: 0.125mg tablet taken 30 minutes prior to dental treatment.